Medical Composites Market Report 2026

Medical Composites Market Overview

• Medical Composites market size has reached to $1.6 billion in 2025 • Expected to grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 14.3% • Growth Driver: Medical Composites Market Driven By Growing Breast Cancer Incidence • Market Trend: Elevating The Medical Composites Market With High-Performance Polymers • North America was the largest region in 2025.

What Is Covered Under Medical Composites Market?

Medical composites refer to a combination of two or more materials that are distinctive from each other in terms of physical and chemical properties. The medical composites are used in diagnostic imaging, biological resurfacing of damaged areas, surgical applications, and dental implants. The main types of medical composites are carbon fiber, ceramic fiber, and other fiber types. Ceramic fibers are small-dimension filament or thread composed of a ceramic material, usually alumina and silica, used in lightweight units for electrical, thermal, and sound insulation. The process used are wet lamination, prepreg, and other processes. The various applications involved diagnostic imaging, composite body implants, surgical instruments, dental, and other applications.

What Is The Medical Composites Market Growth Forecast?

The medical composites market size is expected to see rapid growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing demand for next-generation implant materials, rising investments in biomedical engineering, expansion of personalized medical devices, growing focus on sustainable and recyclable composites, increasing application of composites in advanced diagnostics. Major trends in the forecast period include increasing use of advanced composite materials in implants, rising adoption of lightweight surgical instruments, growing demand for high-strength biocompatible materials, expansion of composite applications in diagnostic imaging, enhanced focus on material durability and performance.

Global Medical Composites Market Segmentation

1) By Fiber Type: Carbon Fiber, Ceramic Fiber, Other Fiber Types 2) By Process: Wet Lamination, Prepreg, Other Process 3) By Application: Diagnostic Imaging, Composite Body Implants, Surgical Instruments, Dental, Other Applications Subsegments: 1) By Carbon Fiber: Continuous Carbon Fiber, Short Carbon Fiber, Carbon Fiber Reinforced Polymers (CFRP) 2) By Ceramic Fiber: Alumina Fiber, Zirconia Fiber 3) By Other Fiber Types: Glass Fiber, Aramid Fiber

What Is The Driver Of The Medical Composites Market?

The growing incidence of breast cancer is expected to propel the growth of the medical composites market going forward. Breast cancer is a malignant tumor that originates in the cells of the breast. Medical composites in breast cancer care provides materials for the development of lightweight, customized radiation therapy devices and implants, improving patient comfort and treatment effectiveness. For instance, in July 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, each year in the United States, around 240,000 women and 2,100 men receive breast cancer diagnoses, and about 42,000 women and 500 men in the U.S. die each year from breast cancer. Therefore, the growing incidence of breast cancer is driving the growth of the medical composites industry.

Key Players In The Global Medical Composites Market

Major companies operating in the medical composites market are 3M Company, Toray Industries Inc, SGL Carbon SE, CeramTec GmbH, Composiflex Inc, Dentsply Sirona Inc, Mitsubishi Chemical Holdings Corporation, Avient Corporation, Zeus Industrial Products Inc, Kulzer GmbH, Den Mat Holdings LLC, Ivoclar Vivadent Inc, Tokuyama Dental Corporation Inc, Teijin Limited, Koninklijke DSM N V, Fillauer LLC, Getinge Group, Hill Rom Holdings Inc, icotec AG, Nippon Sheet Glass Co Ltd, Ossur, Ottobock SE & Co KG, Owens Corning, Shofu Inc, Stryker Corporation

Global Medical Composites Market Trends and Insights

Major companies operating in the medical composites market are increasing their focus on introducing high-performance polymers, such as Magnolia Trinity PEEK, to gain a competitive edge in the market. Magnolia Trinity PEEK is a medical-grade PEEK composite composed of three clinically proven biomaterials. For instance, in October 2023, Superior Polymers, a US-based polymer company, launched a new medical-grade PEEK composite called Magnolia Trinity PEEK. This composite is designed for use in implantable medical devices that are in contact with bodily fluids or tissue for more than 24 hours. Magnolia Trinity PEEK is an attractive option for medical device manufacturers because the combination of carbon fiber, hydroxyapatite, and PEEK in Magnolia Trinity PEEK provides superior performance in terms of strength, stiffness, and durability.

What Are Latest Mergers And Acquisitions In The Medical Composites Market?

In September 2023, Michelin, a France-based company that specializes in composite polymers, acquired Flex Composite Group for an undisclosed amount. This acquisition aligns with Michelin's Michelin in Motion 2030 strategy and represents a major advancement in the Group's polymer composites development. The new entity will capitalize on Michelin's exceptional innovation and R&D strengths, while benefiting from FCG's deep customer relationships and expertise in industrial processes. Flex Composite Group is a France-based manufacturer of medical composites.

Regional Outlook

North America was the largest region in the medical composites market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Composites Market?

The medical composites market consists of sales of polymer matrix composites, carbon matrix composites, metal matrix composites, and ceramic matrix composites. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.